Latest Breaking News On - Lini pandite - Page 1 : comparemela.com

Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the European Hematology Association (EHA) 2024 Congress

Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the European Hematology Association (EHA) 2024 Congress
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesNorth carolinaLini panditeSamer zeidanConor richardsonExchange commissionShattuck labs incChief medical officerBi functional fusion protein targetingPreviously untreated acute myeloid leukemiaHigher risk myelodysplasticShattuck labsAgonist redirected checkpointAnnual reportSafe harborPrivate securities litigation reform act

Shattuck Labs to Present Additional Data from the Phase 1B

Shattuck Labs to Present Additional Data from the Phase 1B
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesNorth carolinaSamer zeidanLini panditeConor richardsonShattuck labs incExchange commissionChief medical officerBi functional fusion protein targetingPreviously untreated acute myeloid leukemiaHigher risk myelodysplasticShattuck labsAgonist redirected checkpointAnnual reportSafe harborPrivate securities litigation reform act

Shattuck Labs, Inc (NASDAQ:STTK) Q3 2023 Earnings Call Transcript

Operator: Good morning and welcome to the Shattuck Labs Third Quarter 2023 Earnings Conference Call. At this time all participants are in a listen-only mode.

United statesJoe pantginisJonathan millerTaylor schreiberLini panditeAndrew neillConor richardsonScientific coStreamtrack incAmerican society of hematology annual meetingShattuck labs incShattuck labsCall transcript novemberShattuck labs third quarterVice presidentInvestor relations

Shattuck Labs to Report Third-Quarter 2023 Financial Results on November 9, 2023

AUSTIN, TX and DURHAM, NC, Nov. 06, 2023 Shattuck Labs, Inc. , a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic.

United statesNorth carolinaTaylor schreiberLini panditeAndrew neillConor richardsonShattuck labs incShattuck labs third quarterToll free dial in numberDial in numberInvestor relationsShattuck labsAgonist redirected checkpointMedia contact

Shattuck Labs to Report Third-Quarter 2023 Financial Results on November 9, 2023

Shattuck Labs to Report Third-Quarter 2023 Financial Results on November 9, 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNorth carolinaLini panditeAndrew neillConor richardsonTaylor schreiberShattuck labs incReport third quarterShattuck labs third quarterToll free dial in numberDial in numberInvestor relationsShattuck labsAgonist redirected checkpointMedia contact